As of April 22, 2021, the novel coronavirus disease 2019 (COVID-19) has sickened more than
142 million people and taken more than 3 million lives worldwide. 1 Although restrictions …

… Author links open overlay panel Devon E. McMahon BA a , Erin Amerson MD b , Misha
Rosenbach MD c , Jules B. Lipoff MD c , Danna Moustafa BS a , Anisha Tyagi BA a , Seemal R. …

Background Coronavirus disease 2019 (COVID-19) has associated cutaneous manifestations.
Objective To characterize the diversity of cutaneous manifestations of COVID-19 and …

The world’s wealthiest countries have been gripped by resource shortages, including shortages
of personal protective equipment (PPE) and ventilators, during the coronavirus disease …

Background Increasing evidence suggests pernio-like lesions are cutaneous manifestations
of coronavirus infectious disease 2019 (COVID-19). Objective To describe clinical and …

… Author links open overlay panel Devon E. McMahon MD a , Carrie L. Kovarik MD b , William
Damsky MD, PhD c , Misha Rosenbach MD b , Jules B. Lipoff MD b , Anisha Tyagi BA d , …

Background The multimorbid burden and use of systemic immunosuppressants in people
with psoriasis may confer greater risk of adverse outcomes of coronavirus disease 2019 (…

… We read with interest the Comment by Devon E McMahon and colleagues 1 describing the
range … of patients with persistent chilblain lesions, similar to McMahon and colleagues' report. …

To the Editor: The American Academy of Dermatology/International League of Dermatological
Societies COVID-19 Dermatology registry has collected 733 cases of skin reactions …

Emerging infectious diseases are of great importance to public health and clinical practice.
This review aims to characterize the clinical and histopathologic features of emerging …